[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/pages/docs/Risk/index.md) >> Individual ID:PBN__Risk_8754 

# __Lack of certainty in the effectiveness of non-pharmaceutical interventions in countries at earlier stages of the epidemic.__

## Articles mentionning the risk

* [Flaxman_report_2020](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_470.md)

## Mitigations of this risk

* [Conduct ongoing monitoring and evaluation of interventions, and adapt strategies based on new data and insights.](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_10647.md)

## Name of the risk

Potential for higher transmission and increased mortality in countries at earlier stages of the epidemic.

## People affected by this risk

* [Populations in countries at earlier stages of the epidemic](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_7210.md)

## Stakeholders who can mitigate this risk

* [Health authorities and public health organizations](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_7211.md)

## Technologies linked to the risk

* [And forecasting tools for epidemic trends](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_1067.md)
* [Data analytics](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_10337.md)
* [Modeling](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_10447.md)

## This Risk belongs to this RiskGroup

* [Public health risks](https://github.com/mm80843/T3.5/blob/pages/RiskGroup/PBN__RiskGroup_3.md)

